Functional Magnetic Resonance Imaging - Synthetic Aperture Magnetometry (fMRI-SAM) and Alzheimer's Disease

StatusWithdrawn
PhaseNot applicable
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Re-verified, no change to tracked fieldsv13
  2. Study sites: 3 to 0v12
  3. Trial status: Recruiting to Withdrawn
    • Enrollment target: estimated 110 to confirmed 0
    • Site details revised at 3 of 3 sites
    v11
  4. Phase: Not specified to Not applicablev10 Show 4 more changesShow less
    • Trial status: Not Yet Recruiting to Recruiting
    • Start date: Oct 2011 to Apr 2012
    • Study sites: 2 to 3
    • Primary and study completion dates: Aug 2017 to Feb 2018
  5. Trial status: Suspended to Not Yet Recruiting
    • Primary and study completion dates: Dec 2008 to Aug 2017
    • Start date: Jun 2007 to Oct 2011
    • Study sites: 1 to 2
    v9
Show 7 earlier versionsHide 7 earlier versions
  1. Trial status: Recruiting to Suspended
    • Site details revised
    v8
  2. Phase: Not applicable to Not specifiedv7
  3. Eligibility criteria revised
    • Site contact updated
    • Study title expanded, about 8 words
    v6
  4. Re-verified, no change to tracked fieldsv5
  5. Primary completion date: Dec 2008v4
  6. Study completion date: Dec 2008
    • Secondary endpoints: details revised at 1 of 1 entry
    • Site contact updated
    • Study arms: 0 to 3
    v3
  7. Trial status: Not Yet Recruiting to Recruiting
    • Start date: Jun 2007
    • Site details revised
    v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The aim of the protocol is to study the resting brain activation profile of 3 groups of people, using a new fMRI procedure, called fMRI-SAM. fMRI-SAM will be applied to 25 Alzheimer's disease (AD) patients, 25 patients suffering from amnestic - mild cognitive impairment (MCI) - a clinical picture which may be a prodromal form of AD - and 60 healthy controls. The first analysis of the data will search differences of brain activation profiles between the 3 groups. In the second step, the investigators will study the predictive value of fMRI-SAM to detect MCI patients who will later convert to AD.
Trial Details
NCT Number NCT00412048
Lead Sponsor University Hospital, Strasbourg, France
Conditions
(from sponsor)		 Alzheimer's Disease
Related terms Alzheimer Disease
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov